Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (904)	7/9/1997 1:27:00 PM
From: JOHN W.	of 6136

Peter, this is still true. It was my understanding that Crix was the PI if resistance to nelf developed. The most significant point here is that VX-478 has the same problem as Crix. I dont know which of these two should be the second line PI (in 1999). The real sad point of all of this is that financial gain is causing misinformation on which PI is the first-line PI . I read the article in LIFE (July 97), these are real people. Thank God for those charletans at AGPH, that developed the powder and fought for the right for this one little boy to take it. The real reason AGPH was the first to codeveloped the powder with the adult version is because there is no money in it from these kids, so why shoud MRK ever develop a Crix version. A pediatric version of Crix should be developed if you believe Crix is the better PI. When is that going to happen, David S. ?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next